Table 2 Cancer characteristics and their types
Variables | Patients: n (%) |
|---|---|
Cancer type | |
 Solid malignancy | 360 (53.1) |
 Hematologic cancer | 318 (46.9) |
Metastasis | |
 Present | 112 (16.5) |
 Absent | 566 (83.5) |
Treatment intent | |
 Curative | 620 (91.4) |
 Palliative | 58 (8.6) |
Type of chemotherapy | |
 Cytotoxic agents | 508 (74.9) |
 Hormonal agents | 4 (0.6) |
 Monoclonal agents | 3 (0.4) |
 Combinationa | 163 (24) |
Solid malignancy | |
 Gastrointestinal cancer | 89 (13.1) |
 Breast cancer | 64 (9.4) |
 Gynecological cancer | 47 (6.9) |
 Musculoskeletal cancer | 42 (6.2) |
 Genitourinary cancer | 41 (6) |
 Head and neck cancer | 19 (2.8) |
 Neurological cancer | 13 (1.9) |
 Respiratory cancer | 11 (1.6) |
 Others | 34 (5) |
Hematological malignancy | |
 Acute lymphoblastic leukemia | 127 (18.7) |
 Non-Hodgkin lymphoma | 117 (17.3) |
 Acute myelogenous leukemia | 28 (4.1) |
 Chronic lymphocytic leukemia | 17 (2.5) |
 Hodgkin lymphoma | 18 (2.5) |
 Chronic myelogenous leukemia | 7 (1) |
 Others | 5 (0.7) |